Author

A. Moisan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1 Organism:mouse· 1 Research Focus:spatial domain detection· 1

Frequent Co-Authors

A. B. Roth· 1 shared A. Freimoser-Grundschober· 1 shared A. M. Giusti· 1 shared A. Schneider· 1 shared B. Chovelon· 1 shared B. Favier· 1 shared C. Auxenfans· 1 shared C. Belgur· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. B. Roth

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A novel injectable radiopaque hydrogel with potent properties for multicolor CT imaging in the context of brain and cartilage regenerative therapy

M. Said, C. Tavakoli, C. Dumot, K. Toupet, Y. C. Dong, N. Collomb, C. Auxenfans, A. Moisan, B. Favier, B. Chovelon, E. L. Barbier, C. Jorgensen, D. P. Cormode, D. Noel, E. Brun, , R. Auzely-Velty

This paper develops an iodine-labeled hydrogel for multicolor CT imaging to monitor cell and hydrogel distribution in vivo for regenerative therapy.

bioRxiv · Apr 20, 2023 · PreprintBioengineering

In vitro replicative potential of an HIV-1/MO intergroup recombinant virus compared to HIV-1/M and HIV-1/O parental viruses

A. Moisan, F. De Oliveira, M. Vautrin, E. Alessandri-Gradt, T. Mourez, J.-C. Plantier

This study compares the in vitro replicative potential of HIV-1/MO recombinant viruses to HIV-1/M and HIV-1/O parental viruses, finding a hybrid behavior in the recombinant.

bioRxiv · Oct 24, 2022 · PreprintMicrobiology

Human immunocompetent Organs-on-Chips platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies

L. Cabon, D. Petropolis, W. Tien-Street, P. R. Ng, H. S. Grant, K. Karalis, G. A. Hamilton, J. Sam, T. Weinzierl, T. Fauti, A. Freimoser-Grundschober, J. Eckmann, C. Hage, M. Geiger, V. Micallef, , R. Barrile

The paper demonstrates that human immunocompetent Organs-on-Chips can predict safety liabilities of T-cell bispecific antibodies targeting tumor antigens.

bioRxiv · Feb 22, 2021Cancer Biology